CDXC News .68 Clinical Safety Data for ChromaDex®
Post# of 144503
CDXC News .68 Clinical Safety Data for ChromaDex®'s Patented pTeroPure® (pterostilbene) Released at 6th World Congress on Polyphenols Applications in Paris
2012-06-13 06:30 ET - News Release
No major adverse events with pterostilbene consumption in humans
IRVINE, Calif., June 13, 2012 /PRNewswire/ -- ChromaDex Corporation (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries announced today its patented pTeroPure (pterostilbene) was shown to be safe for human consumption according to data from the first clinical trial of the substance. The findings, based on a study with pTeroPure, were presented at the 6th World Congress on Polyphenols Applications in Paris, France on June 7, 2012.(1) Pterostilbene is an antioxidant found in blueberries and other berries and believed by many experts to have a number of health benefits. pTeroPure was named the 2010 North American Most Promising Ingredient of the Year by the independent research company, Frost & Sullivan.
(0)
(0)